Zhitong Finance App News, Shengxiang Biotech (688289.SH) announced that the company's fully automated nucleic acid processing system (S-S13E-P/S-S13E-P1) recently obtained EU CEIVDR certification. The equipment can automate the entire process from sample to report, including sample tube opening, pipetting, nucleic acid extraction, PCR system construction, encapsulation amplification, and result analysis. It has the characteristics of efficient processing, accurate detection, intelligent control, and wide compatibility. Testing programs are rich, covering categories such as HPV, STDs, hematogenesis, respiratory tract, insect vectors, drug genomics, etc., and are suitable for various professional application scenarios such as laboratories, hospitals, testing centers, etc., and efficiently meet diverse needs such as sample testing and experimental analysis within a limited space.

Zhitong Finance App News, Shengxiang Biotech (688289.SH) announced that the company's fully automated nucleic acid processing system (S-S13E-P/S-S13E-P1) recently obtained EU CEIVDR certification. The equipment can automate the entire process from sample to report, including sample tube opening, pipetting, nucleic acid extraction, PCR system construction, encapsulation amplification, and result analysis. It has the characteristics of efficient processing, accurate detection, intelligent control, and wide compatibility. Testing programs are rich, covering categories such as HPV, STDs, hematogenesis, respiratory tract, insect vectors, drug genomics, etc., and are suitable for various professional application scenarios such as laboratories, hospitals, testing centers, etc., and efficiently meet diverse needs such as sample testing and experimental analysis within a limited space.